News Briefs

Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 bln
November 5, 2021 - 9:15 am

Pfizer Inc (PFE.N) said it expected 2021 sales of the COVID-19 vaccine it developed with German partner BioNTech SE to reach $36 billion and forecast another $29 billion from the shot in 2022, topping analyst estimates for both years.

The U.S. drugmaker said it is seeking to sign more vaccine deals with countries, which could drive sales even higher next year. It has the capacity to produce 4 billion doses in 2022 and has based its projections on sales of 1.7 billion doses.

Source: Reuters

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-raises-covid-19-vaccine-sales-forecast-36-billion-2021-11-02/

News Briefs

Trivia

What we can learn from the 1918 Flu Pandemic as the Omicron variant spreads
What we can learn from the 1918 Flu Pandemic as the Omicron variant spreads

Historically, most pandemics end within 2 to 3 years as the virus mutates into a less virulent pathogen and the population builds up immunity. This is what happened to the influenza strain behind the 1918 flu pandemic.

Twitter Handle

Copyright © 2021 I Daily Remedy